Wan Pang

Shanghai, 201418, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Discovery, synthesis, and biological evaluation of N,N'-diacyl-m-phenylenediamine derivatives as novel PCSK9 small-molecule inhibitors.

Discovery, synthesis, and biological evaluation of N,N'-diacyl-m-phenylenediamine derivatives as novel PCSK9 small-molecule inhibitors.

Journal: European journal of medicinal chemistry

Published: April 27, 2026

USP13 promotes enzalutamide resistance by catalyzing depolyubiquitination of PCMT1 in prostate cancer.

USP13 promotes enzalutamide resistance by catalyzing depolyubiquitination of PCMT1 in prostate cancer.

Journal: Cell death & disease

Published: December 29, 2025

Design, synthesis and evaluation of vanillin derivatives as dual-target inhibitors for the treatment of Alzheimer's disease.

Design, synthesis and evaluation of vanillin derivatives as dual-target inhibitors for the treatment of Alzheimer's disease.

Journal: Bioorganic & medicinal chemistry

Published: March 23, 2025

Zinc-dependent Zip7-MAZ-MYBL2 axis promotes prostate cancer metastasis.

Zinc-dependent Zip7-MAZ-MYBL2 axis promotes prostate cancer metastasis.

Journal: Communications biology

Published: February 26, 2025

Design, synthesis and evaluation of diphenyl ether-based kaiso inhibitors with enhanced potency.

Design, synthesis and evaluation of diphenyl ether-based kaiso inhibitors with enhanced potency.

Journal: Bioorganic & medicinal chemistry letters

Published: December 12, 2024

Loss of RNF41 promotes bladder cancer metastasis through increasing NUDC stability to enhance tubulin polymerization.

Loss of RNF41 promotes bladder cancer metastasis through increasing NUDC stability to enhance tubulin polymerization.

Journal: Cell death & disease

Published: November 28, 2024

Discovery and synthesis of novel phenoxyacetate ester Schiff base α-glucosidase inhibitors.

Discovery and synthesis of novel phenoxyacetate ester Schiff base α-glucosidase inhibitors.

Journal: Bioorganic chemistry

Published: September 30, 2024

Design, synthesis and biological evaluation of sulfamethazine derivatives as potent neuraminidase inhibitors.

Design, synthesis and biological evaluation of sulfamethazine derivatives as potent neuraminidase inhibitors.

Journal: Future medicinal chemistry

Published: July 11, 2024

Design, synthesis, and biological activity evaluation of new tankyrase-2 directed inhibitors.

Design, synthesis, and biological activity evaluation of new tankyrase-2 directed inhibitors.

Journal: Chemical biology & drug design

Published: May 13, 2023

Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.

Design, synthesis and biological evaluation of novel 1, 3, 4-oxadiazole derivatives as potent neuraminidase inhibitors.

Journal: Bioorganic & medicinal chemistry

Published: October 17, 2021

Copper-catalyzed three-component reaction of arylhydrazine hydrochloride, DABSO, and NFSI for the synthesis of arenesulfonyl fluorides.

Copper-catalyzed three-component reaction of arylhydrazine hydrochloride, DABSO, and NFSI for the synthesis of arenesulfonyl fluorides.

Journal: Organic & biomolecular chemistry

Published: October 04, 2021

Design, synthesis and biological evaluation of dihydrofurocoumarin derivatives as potent neuraminidase inhibitors.

Design, synthesis and biological evaluation of dihydrofurocoumarin derivatives as potent neuraminidase inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: November 02, 2020

Showing 1-12 of 18

Last Updated: 09/26/2026